SYSMEX Stock
SYSMEX Stock price
Key metrics
Is SYSMEX a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.
SYSMEX Stock Analysis
Analyst Opinions
21 Analysts have issued a SYSMEX forecast:
Analyst Opinions
21 Analysts have issued a SYSMEX forecast:
Financial data from SYSMEX
| Mar '25 |
+/-
%
|
||
| Revenue | 508,643 508,643 |
10%
10%
|
|
| Gross Profit | 271,978 271,978 |
12%
12%
|
|
| EBITDA | 129,827 129,827 |
11%
11%
|
EBIT (Operating Income) EBIT | 90,794 90,794 |
13%
13%
|
| Net Profit | 53,669 53,669 |
8%
8%
|
|
In millions JPY.
Don't miss a Thing! We will send you all news about SYSMEX directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
| Head office | Japan |
| CEO | Hisashi Ietsugu |
| Employees | 10,042 |
| Founded | 1968 |
| Website | www.sysmex.co.jp |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
